|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingPhase 1IIT A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Etoricoxib 120 mg Film-coated Tablets and Reference Product (ARCOXIA) in Healthy Thai Volunteers under Fasting Conditions
A Bioequivalence Study of Two Azithromycin Tablet Formulations in Indonesian Healthy Subjects
The aim of this study is to assess the bioequivalence of 500 mg Azithromycin FC tablets (Azivol) produced by PT. Novell Pharmaceutical Laboratories, compared to the reference product Zithromax 500 mg FC tablet produced by Pfizer Australia Pty, Ltd
100 Clinical Results associated with PT Novell Pharmaceutical Laboratories
0 Patents (Medical) associated with PT Novell Pharmaceutical Laboratories
100 Deals associated with PT Novell Pharmaceutical Laboratories
100 Translational Medicine associated with PT Novell Pharmaceutical Laboratories